A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the March 7 2013 Nature by Prof Dimmler, Boon, and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Electroacupuncture therapy for ageing-related cardiac diseases: Electroacupuncture improves myocardial function and inhibits cardiac ageing via up regulation of PNUTS/ PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10). Electroacupuncture, by increasing the expression of PNUTS/PPP1R10 in cardiomyocytes, it may: (1) improve cardiac function after myocardial infarction; (2) and prevent ageing/stress-associated decline in cardiac function. Together, this study reinforces the notion–with a detailed mechanistic basis–that Electroacupuncture therapy may be used as a therapy of choice for cardiac patients. Therefore, physicians may consider recommending their cardiac patients to under go Electroacupuncture therapy.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Undisclosed information: How Electroacupuncture therapy increases the expression of PNUTS/PPP1R10 and prevents ageing/stress-associated decline in cardiac function
Amount: $500*
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Electroacupuncture therapy for ageing-related cardiac diseases: Electroacupuncture improves myocardial function and inhibits cardiac ageing via up regulation of PNUTS/ PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 1/March/2015, 21.38, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation